Clinical Trial Update: A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update of SHR-A1921 in subjects with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• SHR-A1921

Snippet

Sponsor: Atridia Pty Ltd. | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED